The clinical efficacy of a new cephem antibiotic, cefepime (CFPM), was investigated in 8 patients: 6 with secondary infection, 1 with impetigo contagiosa, and 1 with pyoderma. The result was excellent in 5, good in 1 and fair in 2. No side effects were observed except for slight elevation of GOT in 1 case which was rapidly improved after discontinuation of the drug. We think cefepime is a safe and useful adjunct to conventional antibiotics in the treatment of dermatological infectious diseases.
|Number of pages||3|
|Publication status||Published - 1991|
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)
- Infectious Diseases
- Drug Discovery